GILD
Gilead Sciences, Inc.
128.63
2 x 122.25
1 x 134.04
bid
ask
+
2.66
2.11%
10:15 AM
timesize
| Ytd | 4.79% | |
| 1y | 15.35% |
126.46
day range
128.96
108.22
52 week range
155.80
| Open | 126.72 | Prev Close | 125.97 | Low | 126.46 | High | 128.96 | Mkt Cap | 159.73B |
| Vol | 461.50K | Avg Vol | 7.17M | EPS | 7.34 | P/E | 17.53 | Forward P/E | 13.04 |
| Beta | 0.33 | Short Ratio | 3.02 | Inst. Own | 92.16% | Dividend | 3.28 | Div Yield | 2.60 |
| Ex Div Date | 06-15 | Earning | 08-06 | 50-d Avg | 129.64 | 200-d Avg | 129.83 | 1yr Est | 157.57 |
| Income Statement | |||
| Total Revenue | 6.96B | ||
| Revenues (USD) | 6.96B | ||
| Cost of Revenue | 1.45B | ||
| Gross Profit | 5.52B | ||
| Operating Expenses | 2.93B | ||
| Research and Development Expense | 1.37B | ||
| Selling, General and Administrative Expense | 1.45B | ||
| Operating Income | 2.59B | ||
| Interest Expense | 240.00M | ||
| Income Tax Expense | 559.00M | ||
| Net Income | 2.02B | ||
| Net Income Common Stock | 2.02B | ||
| Net Income Common Stock (USD) | 2.02B | ||
| Consolidated Income | 2.02B | ||
| Earnings per Basic Share | 1.63 | ||
| Earnings per Basic Share (USD) | 1.63 | ||
| Earnings per Diluted Share | 1.61 | ||
| Dividends per Basic Common Share | 0.82 | ||
| Earning Before Interest & Taxes (EBIT) | 2.82B | ||
| Earning Before Interest & Taxes (USD) | 2.82B | ||
| Weighted Average Shares | 1.24B | ||
| Weighted Average Shares Diluted | 1.25B | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.63B | ||
| Cash and Equivalents (USD) | 7.63B | ||
| Investments | 998.00M | ||
| Investments Current | 15.00M | ||
| Investments Non-Current | 983.00M | ||
| Trade and Non-Trade Receivables | 4.74B | ||
| Current Assets | 18.64B | ||
| Property, Plant & Equipment Net | 5.64B | ||
| Total Assets | 56.28B | ||
| Debt Current | 1.31B | ||
| Total Debt | 22.17B | ||
| Current Liabilities | 9.48B | ||
| Debt Non-Current | 20.86B | ||
| Total Liabilities | 32.85B | ||
| Accumulated Retained Earnings (Deficit) | 14.13B | ||
| Accumulated Other Comprehensive Income | 78.00M | ||
| Shareholders Equity | 23.52B | ||
| Shareholders Equity (USD) | 23.52B | ||
| Assets Non-Current | 37.64B | ||
| Total Debt (USD) | 22.17B | ||
| Goodwill and Intangible Assets | 24.70B | ||
| Inventory | 1.91B | ||
| Liabilities Non-Current | 23.37B | ||
| Trade and Non-Trade Payables | 645.00M | ||
| Tax Assets | 1.77B | ||
| Tax Liabilities | 1.31B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 689.00M | ||
| Net Cash Flow from Financing | -4.24B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 65.00M | ||
| Capital Expenditure | -117.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -109.00M | ||
| Issuance (Purchase) of Equity Shares | -253.00M | ||
| Issuance (Repayment) of Debt Securities | -2.77B | ||
| Payment of Dividends & Other Cash Distributions | -1.04B | ||
| Net Cash Flow from Investing | 1.77B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.01B | ||
| Net Cash Flow from Operations | 2.54B | ||
| Effect of Exchange Rate Changes on Cash | -11.00M | ||
| Share Based Compensation | 218.00M | ||